Like other medicines with mu-opioid agonist activity, NUCYNTA® is contraindicated in clients with major respiratory despair in unmonitored configurations or even the absence of resuscitative equipment. NUCYNTA® (tapentadol) is indicated for the relief of moderate to critical acute soreness in people 18 several years of age or more mature. In https://altonb061umd8.get-blogging.com/profile